Why Canva’s “Present and Record” feature is still restricted in India and how the interim injunction in the RxPrism patent dispute continues to operate.
Read more about Why Canva’s “Present and Record” Feature Is Still Restricted in India?Tag: patent infringement India
Risdiplam – Spinal Muscular Atrophy Case: Delhi HC Favors Public Health Over Roche Patent
The Delhi High Court, in a significant ruling dated March 24th, 2024, rejected the interim injunction application of F Hoffmann-La Roche AG (“Roche”) against Natco...
Read more about Risdiplam – Spinal Muscular Atrophy Case: Delhi HC Favors Public Health Over Roche PatentProduct by Process Patent Claims are Product Claims, not Process Claims, rules the Delhi High Court
The Delhi High Court has ruled that product by process patent claims are to be treated as product claims, not process claims, for both patentability and infringement analysis. This judgment clarifies the legal position and ensures consistent standards for evaluating pharmaceutical and other complex inventions in India.
Read more about Product by Process Patent Claims are Product Claims, not Process Claims, rules the Delhi High CourtMitigating Patent Risks
This post examines key strategies for mitigating patent risks in India, focusing on design around, licensing, and invalidation. It provides legal analysis and practical examples for businesses facing patent enforcement challenges.
Read more about Mitigating Patent Risks